Mohs AM - Search Results

1

Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.

Feng Y, Jeong EK, Mohs AM, Emerson L, Lu ZR. Feng Y, et al. Among authors: mohs am. Magn Reson Med. 2008 Dec;60(6):1347-52. doi: 10.1002/mrm.21791. Magn Reson Med. 2008. PMID: 19025902 Free PMC article.

2

Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer.

Muilenburg KM, Isder CC, Radhakrishnan P, Batra SK, Ly QP, Carlson MA, Bouvet M, Hollingsworth MA, Mohs AM. Muilenburg KM, et al. Among authors: mohs am. Cancer Lett. 2023 May 1;561:216150. doi: 10.1016/j.canlet.2023.216150. Epub 2023 Mar 29. Cancer Lett. 2023. PMID: 36997106 Free PMC article. Review.

3

Fatty Acid Synthase Inhibitors Enhance Microtubule-Stabilizing and Microtubule-Destabilizing Drugs in Taxane-Resistant Prostate Cancer Cells.

Souchek JJ, Laliwala A, Houser L, Muraskin L, Vu Q, Mohs AM. Souchek JJ, et al. Among authors: mohs am. ACS Pharmacol Transl Sci. 2023 Nov 6;6(12):1859-1869. doi: 10.1021/acsptsci.3c00182. eCollection 2023 Dec 8. ACS Pharmacol Transl Sci. 2023. PMID: 38093839 Free PMC article.

4

PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.

Mohs AM, Wang X, Goodrich KC, Zong Y, Parker DL, Lu ZR. Mohs AM, et al. Bioconjug Chem. 2004 Nov-Dec;15(6):1424-30. doi: 10.1021/bc049828r. Bioconjug Chem. 2004. PMID: 15546211

5

Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.

Zong Y, Wang X, Goodrich KC, Mohs AM, Parker DL, Lu ZR. Zong Y, et al. Among authors: mohs am. Magn Reson Med. 2005 Apr;53(4):835-42. doi: 10.1002/mrm.20402. Magn Reson Med. 2005. PMID: 15799038 Free article.

6

PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI.

Mohs AM, Zong Y, Guo J, Parker DL, Lu ZR. Mohs AM, et al. Biomacromolecules. 2005 Jul-Aug;6(4):2305-11. doi: 10.1021/bm050194g. Biomacromolecules. 2005. PMID: 16004476

7

Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.

Zong Y, Guo J, Ke T, Mohs AM, Parker DL, Lu ZR. Zong Y, et al. Among authors: mohs am. J Control Release. 2006 May 30;112(3):350-6. doi: 10.1016/j.jconrel.2006.03.006. Epub 2006 May 2. J Control Release. 2006. PMID: 16631270

8

Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.

Mohs AM, Lu ZR. Mohs AM, et al. Expert Opin Drug Deliv. 2007 Mar;4(2):149-64. doi: 10.1517/17425247.4.2.149. Expert Opin Drug Deliv. 2007. PMID: 17335412 Review.

9

Modification of Gd-DTPA cystine copolymers with PEG-1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography.

Mohs AM, Nguyen T, Jeong EK, Feng Y, Emerson L, Zong Y, Parker DL, Lu ZR. Mohs AM, et al. Magn Reson Med. 2007 Jul;58(1):110-118. doi: 10.1002/mrm.21270. Magn Reson Med. 2007. PMID: 17659618 Free article.

10

Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.

Lu ZR, Mohs AM, Zong Y, Feng Y. Lu ZR, et al. Among authors: mohs am. Int J Nanomedicine. 2006;1(1):31-40. doi: 10.2147/nano.2006.1.1.31. Int J Nanomedicine. 2006. PMID: 17722260 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters